ID

34184

Descrizione

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention; ODM derived from: https://clinicaltrials.gov/show/NCT01442792

collegamento

https://clinicaltrials.gov/show/NCT01442792

Keywords

  1. 15/01/19 15/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

15 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Cardiovascular Disease, Coronary Artery Disease NCT01442792

Eligibility Cardiovascular Disease, Coronary Artery Disease NCT01442792

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female subject aged 18 years or more with no upper age limit and willing to comply with the protocol
Descrizione

ID.1

Tipo di dati

boolean

symptomatic coronary artery disease due to undergo an elective (non-emergent) percutaneous coronary intervention (pci) on one or two lesions in the native coronary vessel(s). cardiac standard troponin at baseline is within the normal limits
Descrizione

ID.2

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
conditions that may increase the risk of the pci procedure
Descrizione

ID.3

Tipo di dati

boolean

conditions that may increase the risk of bleeding
Descrizione

ID.4

Tipo di dati

boolean

significant valvular heart disease
Descrizione

ID.5

Tipo di dati

boolean

calculated creatinine clearance ≤30 ml/min
Descrizione

ID.6

Tipo di dati

boolean

current use of anticoagulant drugs including vitamin k antagonist (vka), factor iia or factor xa inhibitors
Descrizione

ID.7

Tipo di dati

boolean

chronic treatment with non-steroidal anti-inflammatory drugs (nsaids)
Descrizione

ID.8

Tipo di dati

boolean

chronic treatment with aspirin > 100mg
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Cardiovascular Disease, Coronary Artery Disease NCT01442792

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male or female subject aged 18 years or more with no upper age limit and willing to comply with the protocol
boolean
ID.2
Item
symptomatic coronary artery disease due to undergo an elective (non-emergent) percutaneous coronary intervention (pci) on one or two lesions in the native coronary vessel(s). cardiac standard troponin at baseline is within the normal limits
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
conditions that may increase the risk of the pci procedure
boolean
ID.4
Item
conditions that may increase the risk of bleeding
boolean
ID.5
Item
significant valvular heart disease
boolean
ID.6
Item
calculated creatinine clearance ≤30 ml/min
boolean
ID.7
Item
current use of anticoagulant drugs including vitamin k antagonist (vka), factor iia or factor xa inhibitors
boolean
ID.8
Item
chronic treatment with non-steroidal anti-inflammatory drugs (nsaids)
boolean
ID.9
Item
chronic treatment with aspirin > 100mg
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial